Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 06 2022
Historique:
revised: 26 11 2021
received: 03 08 2021
accepted: 03 01 2022
pubmed: 26 1 2022
medline: 20 4 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

Limited number of tumor types have been examined for Orthopedia Homeobox (OTP) expression. In pulmonary carcinoids, loss of expression is a strong indicator of poor prognosis. Here, we investigated OTP expression in 37 different tumor types, and the association between OTP expression and DNA methylation levels in lung neuroendocrine neoplasms. We analyzed publicly available multi-omics data (whole-exome-, whole-genome-, RNA sequencing and Epic 850K-methylation array) of 58 typical carcinoids, 27 atypical carcinoids, 69 large cell neuroendocrine carcinoma and 51 small cell lung cancer patients and TCGA (The Cancer Genome Atlas) data of 33 tumor types. 850K-methylation analysis was cross-validated using targeted pyrosequencing on 35 carcinoids. We report bimodality of OTP expression in carcinoids (OTP

Identifiants

pubmed: 35076935
doi: 10.1002/ijc.33939
pmc: PMC9303689
doi:

Substances chimiques

Biomarkers, Tumor 0
Homeodomain Proteins 0
Nerve Tissue Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1987-1997

Informations de copyright

© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

J Pathol. 2017 Mar;241(4):488-500
pubmed: 27873319
Ann Oncol. 2015 Aug;26(8):1604-20
pubmed: 25646366
J Thorac Oncol. 2018 Jun;13(6):752-766
pubmed: 29454048
Nat Biotechnol. 2010 Oct;28(10):1057-68
pubmed: 20944598
Ann Oncol. 2021 Apr;32(4):439-451
pubmed: 33482246
Lung Cancer. 2019 Aug;134:85-95
pubmed: 31320001
Eur J Cancer. 2013 May;49(8):1975-83
pubmed: 23352435
Nat Genet. 2009 Dec;41(12):1350-3
pubmed: 19881528
J Thorac Oncol. 2014 Mar;9(3):273-84
pubmed: 24518085
Nat Genet. 2012 Oct;44(10):1104-10
pubmed: 22941188
Gigascience. 2020 Oct 30;9(11):
pubmed: 33124659
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Nat Commun. 2018 Mar 13;9(1):1048
pubmed: 29535388
Cancer Res. 2019 Sep 1;79(17):4339-4347
pubmed: 31300474
Endocr Pathol. 2017 Mar;28(1):60-70
pubmed: 27873160
Endocr Pathol. 2021 Mar;32(1):154-168
pubmed: 33641055
Endocr Pathol. 2019 Mar;30(1):35-42
pubmed: 30523500
Clin Cancer Res. 2011 Jul 1;17(13):4225-31
pubmed: 21558408
Nat Commun. 2014 Mar 27;5:3518
pubmed: 24670920
Nat Commun. 2019 Aug 20;10(1):3407
pubmed: 31431620
Nat Genet. 2009 Feb;41(2):178-186
pubmed: 19151715
J Thorac Oncol. 2020 Oct;15(10):1577-1598
pubmed: 32663527
Cancers (Basel). 2022 Jun 30;14(13):
pubmed: 35805004
Clin Cancer Res. 2013 Apr 15;19(8):2197-207
pubmed: 23444222
J Clin Endocrinol Metab. 2014 Feb;99(2):E374-8
pubmed: 24276465
Neuroendocrinology. 2015;101(3):246-55
pubmed: 25791280
Cell. 2013 Apr 25;153(3):666-77
pubmed: 23622249
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597385
Eur Respir J. 2016 Feb;47(2):615-24
pubmed: 26541538
Cancer Cell. 2019 Jul 8;36(1):17-34.e7
pubmed: 31287989
J Am Soc Cytopathol. 2019 Jan - Feb;8(1):39-46
pubmed: 30929758
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
Cancer Cytopathol. 2018 Apr;126(4):236-242
pubmed: 29316326
Int J Cancer. 2022 Jun 15;150(12):1987-1997
pubmed: 35076935
J Thorac Oncol. 2017 Mar;12(3):425-436
pubmed: 27890494

Auteurs

Laura Moonen (L)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Lise Mangiante (L)

Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), Lyon, France.

Daphne J G Leunissen (DJG)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Lisa M V Lap (LMV)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Aurelie Gabriel (A)

Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), Lyon, France.

Lisa M Hillen (LM)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Guido M Roemen (GM)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Alexander Koch (A)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Epify BV, Maastricht, The Netherlands.

Manon van Engeland (M)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Anne-Marie C Dingemans (AC)

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Matthieu Foll (M)

Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), Lyon, France.

Nicolas Alcala (N)

Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), Lyon, France.

Lynnette Fernandez-Cuesta (L)

Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organisation (IARC/WHO), Lyon, France.

Jules L Derks (JL)

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Ernst-Jan M Speel (EM)

Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH